Six-amino acid ghrelin agonist. Notable for pronounced hunger stimulation in addition to GH release.
Older GHRP class. Stronger appetite signal makes it useful for cachexia models but problematic for body-composition users. Largely superseded by ipamorelin in modern stacks.
Hunger stimulation can backfire for fat-loss goals. Modern alternatives (ipamorelin) are usually preferred.
His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂ (6 aa with D-stereoisomers).
Per-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Pre-filled with this compound's published dose range: 100-200 µg · 2-3x daily, subcutaneous
Calculator is a discussion tool. Verify reconstitution + dosing with a qualified provider. Stack is not a prescription source. Use sterile technique and inspect every vial.
Expected reclassification — PCAC review Feb 2027
FDA's Pharmacy Compounding Advisory Committee scheduled to review the second cohort of peptides removed from Category 2 in April 2026. Panel votes whether to add each to the official 503A bulks list.